Co-careldopa (levodopa with carbidopa)

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Co-careldopa (levodopa with carbidopa) and local guidelines before prescribing.

Dopamine precursor

Mechanism

Levodopa is a dopamine precursor; carbidopa blocks peripheral decarboxylation.

Uses

Parkinson disease.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Nausea, postural hypotension, dyskinesia, motor fluctuations, hallucinations.

Interactions

Dopamine antagonists (metoclopramide, haloperidol) antagonise; MAOIs; iron and protein reduce absorption.

Contraindications and cautions

Narrow-angle glaucoma, melanoma, psychosis

Monitoring

Motor symptoms, BP

Pregnancy and breastfeeding

Avoid unless essential

Renal and hepatic impairment

Caution in cardiac and hepatic disease

Overdose and reversal

Supportive

Special advice

Give on time every time in hospital (missed doses risk akinetic crisis); avoid prochlorperazine and metoclopramide.

More from the textbook: uses, cautions and other points
Where it is discussed in the book